Castleman's Disease: A Study of a Rare Lymphoproliferative Disorder in a University Hospital
Castleman's disease (CD) is a group of rare lymphoproliferative disorders sharing characteristic clinical and histological features, and usually accompanied by a marked systemic inflammatory response. Three histological patterns of lymph nodes were described: the hyaline-vascular, the plasma-ce...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2009-01-01
|
Series: | Clinical Medicine Insights: Blood Disorders |
Online Access: | https://doi.org/10.4137/CMBD.S2161 |
id |
doaj-2490340336a4416b8d46305e9ffab3cc |
---|---|
record_format |
Article |
spelling |
doaj-2490340336a4416b8d46305e9ffab3cc2020-11-25T01:23:55ZengSAGE PublishingClinical Medicine Insights: Blood Disorders1179-545X2009-01-01210.4137/CMBD.S2161Castleman's Disease: A Study of a Rare Lymphoproliferative Disorder in a University HospitalIbrahiem Saeed Abdul-Rahman0Ali M. Al-Amri1Khalid Qassim Ghallab2Internal Medicine/Nephrology.Internal Medicine/Oncology.Department of Pathology, King Fahd hospital of the University, King Faisal University, saudi Arabia.Castleman's disease (CD) is a group of rare lymphoproliferative disorders sharing characteristic clinical and histological features, and usually accompanied by a marked systemic inflammatory response. Three histological patterns of lymph nodes were described: the hyaline-vascular, the plasma-cell and the mixed types. The former is more common (80%-90%) and tends to be localized. The plasma cell type is more aggressive and usually multicentric. It is interesting that the inflammatory manifestations seem to be related to a lymph node lesion, because the systemic symptoms and inflammatory activity can return to normal after surgical excision or successful medical treatment of the disease. We report here our 15-year experience with this rare disease in King Fahd Hospital of the University, Al-Khobar, Saudi Arabia , focusing on the clinical features, therapy, and patients'outcome.https://doi.org/10.4137/CMBD.S2161 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Ibrahiem Saeed Abdul-Rahman Ali M. Al-Amri Khalid Qassim Ghallab |
spellingShingle |
Ibrahiem Saeed Abdul-Rahman Ali M. Al-Amri Khalid Qassim Ghallab Castleman's Disease: A Study of a Rare Lymphoproliferative Disorder in a University Hospital Clinical Medicine Insights: Blood Disorders |
author_facet |
Ibrahiem Saeed Abdul-Rahman Ali M. Al-Amri Khalid Qassim Ghallab |
author_sort |
Ibrahiem Saeed Abdul-Rahman |
title |
Castleman's Disease: A Study of a Rare Lymphoproliferative Disorder in a University Hospital |
title_short |
Castleman's Disease: A Study of a Rare Lymphoproliferative Disorder in a University Hospital |
title_full |
Castleman's Disease: A Study of a Rare Lymphoproliferative Disorder in a University Hospital |
title_fullStr |
Castleman's Disease: A Study of a Rare Lymphoproliferative Disorder in a University Hospital |
title_full_unstemmed |
Castleman's Disease: A Study of a Rare Lymphoproliferative Disorder in a University Hospital |
title_sort |
castleman's disease: a study of a rare lymphoproliferative disorder in a university hospital |
publisher |
SAGE Publishing |
series |
Clinical Medicine Insights: Blood Disorders |
issn |
1179-545X |
publishDate |
2009-01-01 |
description |
Castleman's disease (CD) is a group of rare lymphoproliferative disorders sharing characteristic clinical and histological features, and usually accompanied by a marked systemic inflammatory response. Three histological patterns of lymph nodes were described: the hyaline-vascular, the plasma-cell and the mixed types. The former is more common (80%-90%) and tends to be localized. The plasma cell type is more aggressive and usually multicentric. It is interesting that the inflammatory manifestations seem to be related to a lymph node lesion, because the systemic symptoms and inflammatory activity can return to normal after surgical excision or successful medical treatment of the disease. We report here our 15-year experience with this rare disease in King Fahd Hospital of the University, Al-Khobar, Saudi Arabia , focusing on the clinical features, therapy, and patients'outcome. |
url |
https://doi.org/10.4137/CMBD.S2161 |
work_keys_str_mv |
AT ibrahiemsaeedabdulrahman castlemansdiseaseastudyofararelymphoproliferativedisorderinauniversityhospital AT alimalamri castlemansdiseaseastudyofararelymphoproliferativedisorderinauniversityhospital AT khalidqassimghallab castlemansdiseaseastudyofararelymphoproliferativedisorderinauniversityhospital |
_version_ |
1725119978616651776 |